{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:25:08Z","timestamp":1781936708113,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jpba.2015.01.035","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T15:45:26Z","timestamp":1422114326000},"page":"444-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography\u2013tandem mass spectrometry with positive\/negative ion-switching electrospray ionization and its application in pharmacokinetic study"],"prefix":"10.1016","volume":"107","author":[{"given":"Yang","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huqun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satter","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.01.035_bib0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd2037","article-title":"Anti-obesity therapies","volume":"5","author":"Melnikova","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jpba.2015.01.035_bib0095","first-page":"591","article-title":"Plasma phentermine levels, weight loss and side-effects","volume":"7","author":"Douglas","year":"1983","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.jpba.2015.01.035_bib0100","first-page":"35","article-title":"Management of obesity and cardiometabolic risk-role of phentermine\/extended release topiramate","volume":"7","author":"Sweeting","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes.: Targets Ther."},{"issue":"2","key":"10.1016\/j.jpba.2015.01.035_bib0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2005.03.053","article-title":"Efficacy and safety of topi-ramate in the treatment of obese subjects with essential hypertension","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpba.2015.01.035_bib0110","series-title":"Clinical Briefing Document, Endocrine and Metabolic Drugs Advisory Committee Meeting","article-title":"New Drug Application 22580: VI-052 Qnexa (phentermine\/topiramate)","author":"Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.jpba.2015.01.035_bib0115","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1586\/erc.10.125","article-title":"Phentermine, topiramate and their combination for the treatment of adiposopathy (\u2018sick fat\u2019) and metabolic disease","volume":"8","author":"Bays","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"9774","key":"10.1016\/j.jpba.2015.01.035_bib0120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jpba.2015.01.035_bib0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jpba.2015.01.035_bib0130","article-title":"Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended-release","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpba.2015.01.035_bib0135","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jpba.2007.02.022","article-title":"A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography\u2013mass spectrometry","volume":"44","author":"Pujadas","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.01.035_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-4347(01)00368-1","article-title":"Fluorometric determination of dl-fenfluramine, dl-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography","volume":"763","author":"Kaddoumi","year":"2001","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.01.035_bib0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jchromb.2006.12.016","article-title":"A novel high sensitivity HPLC assay for topiramate, using 4-chloro-7-nitrobenzofurazan as pre-column fluorescence derivatizing agent","volume":"850","author":"Bahrami","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.01.035_bib0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jchromb.2005.05.032","article-title":"High performance liquid chromatographic determination of topiramate in human serum using UV detection","volume":"822","author":"Bahrami","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.01.035_bib0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/bmc.1273","article-title":"Bioanalytical LC\u2013MS\/MS method validation for plasma determination of topiramate in healthy Indian volunteers","volume":"23","author":"Goswami","year":"2009","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.jpba.2015.01.035_bib0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11596-014-1296-y","article-title":"Development of a liquid chromatography\u2013tandem mass spectrometry method for determination of butoconazole nitrate in human plasma and its application to a pharmacokinetic study","volume":"34","author":"Jia","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol."},{"key":"10.1016\/j.jpba.2015.01.035_bib0165","unstructured":"State Food and Drug Administration, 2005. http:\/\/www.sda.gov.cn\/gsz05106\/08.pdf."},{"key":"10.1016\/j.jpba.2015.01.035_bib0170","series-title":"Guideline on Validation of Bioanalytical Methods (Draft)","year":"2009"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851500045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851500045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T02:26:57Z","timestamp":1537928817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851500045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":17,"alternative-id":["S073170851500045X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.035","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography\u2013tandem mass spectrometry with positive\/negative ion-switching electrospray ionization and its application in pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}